Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Pzena International Value ADR strategy. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+6.3%
YTD+35.3%
Annualized+0.193%
Positioning StanceCONSTRUCTIVE
Market CapLarge Cap
Digest Analysis
Quick Take
"Pzena's International Value ADR strategy gained 6.3% Net in Q4 2025, outperforming the MSCI EAFE Index. The firm capitalized on macro and AI-driven volatility to buy quality names like Accenture, Publicis, and Vale at attractive valuations while trimming strong performers."
Executive Summary
During Q4 2025, non-U.S. equity markets continued their upward trajectory, with value stocks outpacing growth stocks. Pzena International Value ADR Composite returned 6.3% Net (6.4% Gross) for the quarter, outperforming the MSCI EAFE Index (4.9%) but underperforming the MSCI EAFE Value Index (7.8%). The portfolio benefited from absolute performance in financial, healthcare, and IT holdings (ArcelorMittal, Nokia, Bayer), while consumer discretionary and real estate detracted (Alibaba, Galaxy Entertainment, Michelin). Pzena utilized market volatility to add high-quality franchises trading at cheap valuations (Kubota, Publicis, Accenture, Vale, Suntory, Ambev, Daikin) while funding these additions by trimming positions on strength (Komatsu, CaixaBank, Murata). Pzena remains excited about cheap fundamental valuations in a volatile environment.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
80%
Market Conviction
High-conviction positioning: Pzena's International Value ADR strategy gained 6.3% Net in Q4 2025, outperforming the MSCI EAFE Index. The firm capitalized on macro and AI-driven volatility to buy quality names ...
85%
Growth Outlook
Market outlook remains above average conviction: Pzena's International Value ADR strategy gained 6.3% Net in Q4 2025, outperforming the MSCI EAFE Index. The firm capitalized on macro and AI-driven volatility to buy quality names ...
85%
Risk Appetite
Risk appetite posture is above average conviction: Pzena's International Value ADR strategy gained 6.3% Net in Q4 2025, outperforming the MSCI EAFE Index. The firm capitalized on macro and AI-driven volatility to buy quality names ...
80%
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. Pzena's International Value ADR strategy gained 6.3% Net in Q4 2025, outperforming the MSCI EAFE Index. The firm capitalized on macro and AI-driven volatility to buy quality names ...
80%
Forward Guidance
Forward guidance signal: Pzena's International Value ADR strategy gained 6.3% Net in Q4 2025, outperforming the MSCI EAFE Index. The firm capitalized on macro and AI-driven volatility to buy quality names ...
85%
Language Signal
Tone analysis indicates above average conviction language: Pzena's International Value ADR strategy gained 6.3% Net in Q4 2025, outperforming the MSCI EAFE Index. The firm capitalized on macro and AI-driven volatility to buy quality names ...
50%
Perceived Risk
Perceived risk level is evaluated as moderate conviction. Pzena's International Value ADR strategy gained 6.3% Net in Q4 2025, outperforming the MSCI EAFE Index. The firm capitalized on macro and AI-driven volatility to buy quality names ...
80%
Opportunity Density
Opportunity density index indicates high conviction actionable entry points. Pzena's International Value ADR strategy gained 6.3% Net in Q4 2025, outperforming the MSCI EAFE Index. The firm capitalized on macro and AI-driven volatility to buy quality names ...
90%
Time Horizon
Investment time horizon reflects a high conviction orientation. Pzena's International Value ADR strategy gained 6.3% Net in Q4 2025, outperforming the MSCI EAFE Index. The firm capitalized on macro and AI-driven volatility to buy quality names ...